OCTOBER 21, 2021 Strong results in Q3 as we Focus. Together. For patients & society. Today we published our third quarter financial results, which are a powerful demonstration of the impact of our Group strategy, which launched almost a year ago. Our sales grew by 14.9% last quarter, taking our year-to-date (YTD) growth to 12.3%. As a result, we are yet again increasing our guidance for 2021 to greater than 11%. These positive figures are the result of growth in our Specialty Care portfolio, notably in our oncology portfolio. These strong results come at an exciting moment for Ipsen. We’ve added two new partnerships to our pipeline in the last quarter. The first is with Exicure to research, develop, and commercialize novel Spherical Nucleic Acids as potential investigational treatments for Huntington’s disease and Angelman syndrome. The second is with Accent Therapeutics to research, develop, manufacture, and commercialize Accent’s pre-clinical stage METTL3 program, reinforcing our expansion into hematological malignancies, with a focus on acute myeloid leukemia. In total, we have signed four exciting new partnerships since July. As we continue to implement our strategy, Focus. Together. For patients & society, we are guided by clear objectives: to maximize our brands, to build our pipeline, to deliver efficiencies and to boost our culture of collaboration and excellence. We will continue to go above and beyond for the people living with unmet medical needs and to proactively contribute to our communities and to society as a whole. Find more information on our Q3 results here. News Center View all Our pledge: industry-leading action for the climate NEWS Strong results in Q3 as we Focus. Together. For patients & society. NEWS YTD 2021 Sales announcement – Webcast details – 21 October 2021 Our company Our Science Our responsibility Patients Partnering Investors News Center Careers Terms & conditions Data privacy Cookie policy Global Privacy Policy © Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021 Your privacy is important to us By clicking “Accept All” , you agree to the storing of cookies on your device to enhance site navigation, measure site performance and show you personalized advertising. You can manage individual cookies preferences or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third-parties intervening on our website, please consult the Cookies Policy, available in the site footer. Cookies settings Reject all Accept all